Category: Science Blog October 24, 2014
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?
Category: Science Blog September 29, 2014
Something extraordinary is happening right now. Impelled by the Ebola outbreak in West Africa, researchers, medics, funding agencies, pharmaceutical companies a...
Category: Science Blog September 18, 2014
We look at some of the challenges in running childhood cancer clinical trials.
Category: Science Blog August 29, 2014
Depression is an important but largely under-recognised problem for people with cancer, but a new treatment programme could improve quality of life for patients